Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Establishing a glutamine metabolism-based model for predicting the prognosis of low-grade glioma.
Journal: Frontiers in genetics
Published: August 29, 2022
A familiar cerebral cavernous malformations (FCCMs) patient with CCM1 deletion-frameshift mutation generates an induced pluripotent stem cell line (NFHHMUi001-A).
Journal: Stem cell research
Published: May 11, 2022
Pan-cancer analysis of ASB3 and the potential clinical implications for immune microenvironment of glioblastoma multiforme.
Journal: Frontiers in immunology
Published: December 23, 2021
Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 20, 2021
Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme.
Journal: Frontiers in genetics
Published: September 01, 2021
CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors.
Journal: Nature communications
Published: April 13, 2018
The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas.
Journal: Frontiers in molecular neuroscience
Published: October 20, 2017
Last Updated: 09/26/2026